Nevro Corp (NYSE:NVRO)

168.20
Delayed Data
As of Mar 02
 +0.09 / +0.05%
Today’s Change
65.05
Today|||52-Week Range
188.14
-2.83%
Year-to-Date
Nevro (NVRO) Q4 Loss Narrower Than Estimated, Revenues Miss
Feb 25 / Zacks.com - Paid Partner Content
Nevro Corp (NVRO) Q4 2020 Earnings Call Transcript
Feb 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close168.11
Today’s open170.29
Day’s range167.67 - 171.63
Volume179,843
Average volume (3 months)355,123
Market cap$5.7B
Data as of 4:00pm ET, 03/02/2021

Growth & Valuation

Earnings growth (last year)+26.72%
Earnings growth (this year)+10.05%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)-7.23%
P/E ratioNM
Price/Sales16.10
Price/Book14.55

Competitors

 Today’s
change
Today’s
% change
TNDMTandem Diabetes Care...-2.29-2.39%
IRTCiRhythm Technologies...-3.98-2.60%
LIVNLivaNova PLC-0.51-0.66%
----
Data as of 4:00pm ET, 03/02/2021

Financials

Next reporting dateMay 10, 2021
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$362.0M
Annual profit (last year)-$83.1M
Net profit margin-22.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Redwood City, California

Forecasts